<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.3" -->
<rss version="2.0">
	<channel>
		<title>BioElectronics Corporation (OTC:BIEL) Poised for Major Revenue Growth</title>
		<description>Comments for BioElectronics Corporation (OTC:BIEL) Poised for Major Revenue Growth at http://www.biomedreports.com , comment 1 to 10 out of 10 comments</description>
		<link>http://www.biomedreports.com</link>
		<lastBuildDate>Wed, 08 Feb 2012 03:01:25 +0100</lastBuildDate>
        <generator>FeedCreator 1.7.3</generator>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200907132085/bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html#comment-494</link>
			<description>The approval dates are in the fda calendar. Also, yes, I agree that approval in the U.S. will open up the market for their Allay product- since it seems they are already talking to several manufacturers and distributors of feminine hygiene products, who have experienced significant interest. - M.E.Garza</description>
			<pubDate>Wed, 15 Jul 2009 06:40:03 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200907132085/bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html#comment-489</link>
			<description>12-15-09 or so as I understand it. For Female pain. - Alvin Foster</description>
			<pubDate>Tue, 14 Jul 2009 05:03:22 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200907132085/bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html#comment-487</link>
			<description>When is the FDA approval date? What is the anticipation of stock price by Oct 31 - Ravi Koorapati</description>
			<pubDate>Tue, 14 Jul 2009 00:14:32 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200907132085/bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html#comment-485</link>
			<description>Just two words.....Remember Acus - Chris</description>
			<pubDate>Mon, 13 Jul 2009 16:09:23 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200907132085/bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html#comment-484</link>
			<description>Hello,
What revenue growth range are we looking at?
Could we have an ballpark figure of what revenue has been in countries outside the US?
If approved by FDA, I'd think that cpnies like CVS, Rite Aid, Cosco,Wall Mart... would jump on these products since they are unique,safe,efficient; so why would they need such a big sales force? They'd need instead lawyers writting good contracts!
What do you think?
Thank You,
Bernard   - bernard</description>
			<pubDate>Mon, 13 Jul 2009 14:38:02 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200907132085/bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html#comment-483</link>
			<description>Let's take the trip. I'm strapped in. - Alvin Foster</description>
			<pubDate>Mon, 13 Jul 2009 11:01:38 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200907132085/bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html#comment-482</link>
			<description>The new chairman of BIEL

Is it Rick Anderson or Dr. Richard Staelin??
 - Raghav Bhopla</description>
			<pubDate>Mon, 13 Jul 2009 10:49:59 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200907132085/bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html#comment-481</link>
			<description>
Great article, except for one highly important error. BioElectronics Coproration's new Chairman of the Board is Richard Staelin, Phd., not Rick Anderson and none of the close followers of BIEL knows the identity of Rick Anderson. Dr. Staelin is a full professor at Duke University's Fuqua School of Business with long standing knowledge of the details involved in properly preparing and filing INDs with the FDA. Since we are dealing with the Chairman of the Company, it would seem appropriate to print some sort of correction to this unintentional error.
Thanks. - Bruce Watts</description>
			<pubDate>Mon, 13 Jul 2009 08:56:25 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200907132085/bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html#comment-480</link>
			<description>&quot;
The company recently announced a new Chairman.  What can you tell us about that development?

Noel: Rick Anderson, who is a full professor at the Fuqua School, one of the top business school, as part of the Duke University.&quot;

I thought the new chairman was Richard Staelin??? - Rob</description>
			<pubDate>Mon, 13 Jul 2009 07:37:04 +0100</pubDate>
		</item>
		<item>
			<title>...</title>
			<link>http://www.biomedreports.com/200907132085/bioelectronics-corporation-otcbiel-poised-for-major-revenue-growth.html#comment-479</link>
			<description>&quot;
The company recently announced a new Chairman.  What can you tell us about that development?

Noel: Rick Anderson, who is a full professor at the Fuqua School, one of the top business school, as part of the Duke University.&quot;

I thought the new chairman was Richard Staelin??? - Rob</description>
			<pubDate>Mon, 13 Jul 2009 07:35:15 +0100</pubDate>
		</item>
	</channel>
</rss>

